Co-existence of thrombocytopenia and hyperleukocytosis ('critical period') as a risk factor of haemorrhage into the central nervous system in patients with acute leukaemias.
about
Use of cellular and plasma apheresis in the critically ill patient: Part II: Clinical indications and applications.Personal practice: how we manage the risk of bleeding and thrombosis in children and young adults with acute lymphoblastic leukaemia.Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors.How I treat acute myeloid leukemia presenting with preexisting comorbidities.Fatal Cerebral Leucostasis in Acute Leukaemia with Hyperleucocytosis.Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia.
P2860
Co-existence of thrombocytopenia and hyperleukocytosis ('critical period') as a risk factor of haemorrhage into the central nervous system in patients with acute leukaemias.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@ast
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@en
type
label
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@ast
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@en
prefLabel
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@ast
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@en
P2093
P921
P1433
P1476
Co-existence of thrombocytopen ...... atients with acute leukaemias.
@en
P2093
Barbara Zdziarska
Cezary Fryze
Ignacy Urasiński
Przemysław Nowacki
P304
P356
10.1163/15685590160141387
P577
2002-01-01T00:00:00Z